<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9007261</journal-id>
<journal-id journal-id-type="pubmed-jr-id">2076</journal-id>
<journal-id journal-id-type="nlm-ta">Crit Rev Eukaryot Gene Expr</journal-id>
<journal-id journal-id-type="iso-abbrev">Crit. Rev. Eukaryot. Gene Expr.</journal-id>
<journal-title-group>
<journal-title>Critical reviews in eukaryotic gene expression</journal-title>
</journal-title-group>
<issn pub-type="ppub">1045-4403</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27480773</article-id>
<article-id pub-id-type="pmc">5470591</article-id>
<article-id pub-id-type="doi">10.1615/CritRevEukaryotGeneExpr.2016015724</article-id>
<article-id pub-id-type="manuscript">NIHMS842933</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Clinical Genomics: Challenges and Opportunities</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Vijay</surname>
<given-names>Priyanka</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McIntyre</surname>
<given-names>Alexa B.R.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mason</surname>
<given-names>Christopher E.</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Greenfield</surname>
<given-names>Jeffrey P.</given-names>
</name>
<xref ref-type="aff" rid="A3">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Sheng</given-names>
</name>
<xref ref-type="aff" rid="A3">c</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>a</label>Department of Physiology and Biophysics, Weill Cornell Medical College, New York, New York. Tri-Institutional Training Program in Computational Biology and Medicine, Weill Cornell Medical College, New York, New York</aff>
<aff id="A2"><label>b</label>Department of Physiology and Biophysics, Weill Cornell Medical College, New York, New York. Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medical College, New York, New York. Feil Family Brain and Mind Research Institute, New York, New York</aff>
<aff id="A3"><label>c</label>Department of Neurological Surgery, New York-Presbyterian Hospital, Weill Cornell Medical College, New York, New York</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Address all correspondence to: Sheng Li PhD, Department of Neurological Surgery, Weill Cornell Medical College, 525 E. 68<sup>th</sup> Street, Box 99, New York, NY 10021, Phone: 646-697-0052, <email>shl2018@med.cornell.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>11</day>
<month>4</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>14</day>
<month>6</month>
<year>2017</year>
</pub-date>
<volume>26</volume>
<issue>2</issue>
<fpage>97</fpage>
<lpage>113</lpage>
<!--elocation-id from pubmed: 10.1615/CritRevEukaryotGeneExpr.2016015724-->
<abstract>
<p id="P1">Next-generation sequencing (NGS) approaches are highly applicable to clinical studies. We review recent advances in sequencing technologies, as well as their benefits and tradeoffs, to provide an overview of clinical genomics from study design to computational analysis. Sequencing technologies enable genomic, transcriptomic, and epigenomic evaluations. Studies that use a combination of whole genome, exome, mRNA, and bisulfite sequencing are now feasible due to decreasing sequencing costs. Single-molecule sequencing increases read length, with the MinIONâ„¢ nanopore sequencer, which offers a uniquely portable option at a lower cost. Many of the published comparisons we review here address the challenges associated with different sequencing methods. Overall, NGS techniques, coupled with continually improving analysis algorithms, are useful for clinical studies in many realms, including cancer, chronic illness, and neurobiology. We, and others in the field, anticipate the clinical use of NGS approaches will continue to grow, especially as we shift into an era of precision medicine.</p>
</abstract>
<kwd-group>
<kwd>Sequencing</kwd>
<kwd>genomics</kwd>
<kwd>clinical utility</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>